maverickny + immunotherapy   152

Twitter
Response to Tumor | Understanding the influence of the Tumor Immune MicroEnvironment: General Classi…
ImmunoTherapy  from twitter_favs
april 2018 by maverickny
Twitter
Dr K Ranade Head Transl Medicine talks /pre-Tx IFN signature (anti-cancer immunity)better…
immunotherapy  from twitter_favs
april 2018 by maverickny
Twitter
Packed house for resistance session chaired by Tom Gajewski. He also presented his team’s work ident…
immunotherapy  from twitter_favs
april 2018 by maverickny
Twitter
A major theme for the future research in is Tissue-Specific Immunoregulation. Surprisingly we have v…
Immunotherapy  from twitter_favs
april 2018 by maverickny
Twitter
Co-targeting CHK1 w/PD-L1 blocking increases efficacy of in . Dr. Lauren Byers…
Immunotherapy  smallcell  from twitter_favs
april 2018 by maverickny
Twitter
“And then yonder, the clouds parted magically and the healing rays of poured their goodness over our…
immunotherapy  from twitter_favs
april 2018 by maverickny
Twitter
The differences between effective and ineffective immune responses in cancer.
immunotherapy  ImmunoOnc  AACR2018  from twitter_favs
april 2018 by maverickny
Twitter
RT : Potentially interesting paper: "Coordinated responses to individual tumor antigens by IgG antibody a…
immunotherapy  from twitter_favs
april 2018 by maverickny
Twitter
WOW! Dr Jeffrey S. Weber ROCKSTAR /alumn CRP at CA Pt values/Inhibi…
Immunotherapy  melanoma  from twitter_favs
march 2018 by maverickny
Twitter
DCR of 81 % @ 12 weeks, ~ 72 % @ 6 months. > 50% responses ongoing.
sgomtg  SGO2018  Immunotherapy  from twitter_favs
march 2018 by maverickny
Twitter
Cancer | Improved response to antiPD-L1 by blocking TGFb | SanjeevMariathasan & ShannonTurley…
ImmunoTherapy  from twitter_favs
february 2018 by maverickny
Twitter
Preclinical studies of CD47 antibody in an "adjuvant" model of
immunotherapy  PancreaticCancer  from twitter_favs
february 2018 by maverickny
Twitter
Sharma: Nice immune response to self antigen and neoantigens following for prostate cancer
GU18  immunotherapy  from twitter_favs
february 2018 by maverickny
Twitter
CLICK HERE - If you have 2 mins on & want to hear what WORLD EXPERTS think about to…
WorldCancerDay  Immunotherapy  from twitter_favs
february 2018 by maverickny
Twitter
RT : New in the and section of The JI, read the article "Comparison of T Cell Activities Mediat…
ImmunoTherapy  Vaccines  from twitter_favs
january 2018 by maverickny
Twitter
CarlJune's next startup, focused on solid tumor CARs & TCRs, starting w…
immunotherapy  from twitter_favs
january 2018 by maverickny
Twitter
Attending ?
Brush up on an exhaustive biomarkers review, bookended by two of f…
immunotherapy  ImmunoOnc18  from twitter_favs
january 2018 by maverickny
(429) https://twitter.com/i/web/status/952548133740965888
When to stop treatment with ? Not clear, as studies were always designed like trials, w…
chemotherapy  Immunotherapy  from twitter_favs
january 2018 by maverickny
(429) https://twitter.com/i/web/status/952394283021201410
Just noticed that BEAT-MBM: a phase II study of VEGFi (bev) + PDL1 (atezo) for brain metas…
immunotherapy  melanoma  from twitter_favs
january 2018 by maverickny
Twitter
Targeting receptor b-chain for CAR-T therapy Tcell | MartinPule
TCR  Immunotherapy  Tcell  lymphomas  from twitter_favs
december 2017 by maverickny
Twitter
I just couldn't help it. I just had to 3D print my own life-sized model of
immunotherapy  cd47  from twitter_favs
december 2017 by maverickny
Twitter
Hot topic this ASH for will be CAR-T Cell Therapy. I highly recommend listening to this po…
Immunotherapy  Myeloma  from twitter_favs
december 2017 by maverickny
Twitter
This is my perspective on the future of to we can make a difference in…
FINISHCANCER  Immunotherapy  cancer  from twitter_favs
december 2017 by maverickny
Twitter
Dr Ena Wang pioneer & ex- questions speakers in panel discussion 2…
biomarker  immunotherapy  from twitter_favs
december 2017 by maverickny
Twitter
RT : Great review on de-novo and acquired resistance to immune checkpoint targeting
immunotherapy  from twitter_favs
november 2017 by maverickny
Twitter
for T cell Malignancies | AntiTCRb constant region | MartinPule
ImmunoTherapy  CAR_Tcells  from twitter_favs
november 2017 by maverickny
Twitter
Cyclin D-CDK4 destabilizes tumor PD-L1 levels - possible that combination with checkpoint inhibitors…
immunotherapy  from twitter_favs
november 2017 by maverickny
Twitter
When baseline RR to is practically 0%, 10% is a success. $FPRX CSF1R inh in - more…
immunotherapy  PancreaticCancer  from twitter_favs
november 2017 by maverickny
Twitter
Excellent talk by Turajluc. RCC Indels may explain why they have good ORR to with relatively low poi…
immunotherapy  from twitter_favs
october 2017 by maverickny
Twitter
Excellent keynote discussion by Dr. Tom Gajewski on microbiota and response
IBCN  Immunotherapy  from twitter_favs
october 2017 by maverickny
Twitter
Hear Eli Van Allen discuss his recent paper on patients with exceptional responses to
immunotherapy  from twitter_favs
august 2017 by maverickny
DEFINE_ME_WA
Great review

Integrating Next-Generation Dendritic Cell into the Current Landscape
Immunotherapy  Cancer  Vaccines  from twitter_favs
july 2017 by maverickny
Twitter
Management of toxicities from : Clinical Practice Guidelines
immunotherapy  from twitter_favs
july 2017 by maverickny
Twitter
🔮Dr Pat Hwu with a rapid-fire look into the crystal ball for promising novel tx strategies
immunotherapy  ASCO17  from twitter_favs
june 2017 by maverickny
Twitter
Next up - combination of $REGN aPD-1 with Sarilumab
Lots of stromal IL-6 in that…
immunotherapy  PancreaticCancer  from twitter_favs
may 2017 by maverickny
Twitter
CAR T cell review & strategies to enhance T-cell persistence
Immunotherapy  from twitter_favs
april 2017 by maverickny
DEFINE_ME_WA
CAR T cell review & strategies to enhance T-cell persistence
Immunotherapy  from twitter_favs
april 2017 by maverickny
Twitter
Fantastic talk by Tom Gajewski insights into novel mechanisms/target…
immunotherapy  from twitter_favs
april 2017 by maverickny
Twitter
Cath Bollard talking beyond CARs in joint cell therapy session at
immunotherapy  EBV  ebmt17  from twitter_favs
march 2017 by maverickny
Twitter
I guess we are seeing the normalization of the "irrational exuberance" regarding combinations
Immunotherapy  from twitter_favs
march 2017 by maverickny
Video - VJHemOnc
Hagop does mention it here but notable that we can cure many elderly patients w/ alloSCT, an .
immunotherapy  AML  from twitter_favs
march 2017 by maverickny
Twitter
Free Locke Late Breaker -Cel -T for . Remarkable responses in high ris…
lymphoma  CAR-T  Immunotherapy  Axi-Cel  BMTTandem17  from twitter_favs
february 2017 by maverickny
Twitter
Final talk in wonderful Plenary: Emma Morris Transgenic TCR to attack intracellular tar…
immunotherapy  BMTTandem17  from twitter_favs
february 2017 by maverickny
Twitter
Fong: vingette 1--adenosine antagonist and rationale, preclinical and select clinical data
immunosym  Immunotherapy  from twitter_favs
february 2017 by maverickny
Twitter
Key step to increase the number of patients who will benefit from T-cell based
Immunotherapy  from twitter_favs
february 2017 by maverickny
Twitter
Summary of and her student's work on & responses in (also includes…
immunotherapy  melanoma  microbiome  from twitter_favs
february 2017 by maverickny
Twitter
If correct this has significant implications for directed including strategies for…
immunotherapy  biopsy  from twitter_favs
february 2017 by maverickny
« earlier      
per page:    204080120160

related tags

AACR15  AACR16  AACR2018  AAI2015  abscopal  acs  aml  asco  ASCO15  ASCO17  atezolizumab  autoimmunity  awalkwithpurpose  Axi-Cel  biomarker  biopsy  bladdercancer  BMTTandem17  Breaking  breastcancer  bridge2017  cancer  CancerImmune  cancermoonshot  CAR-T  CAR_Tcells  cd47  chemotherapy  CICON16  CIMchat  ClinicalTrial  clinicaltrials  CRC  cri  CRISPR  CRIWebinar  crowdfunding  cytokine  drugdevelopment  ebmt17  EBV  endcancer  esmo  FINISHCANCER  FirstInHuman  GI16  GU18  hpv  IBCN  Immunit  immunobiology  immunology2015  ImmunoOnc  ImmunoOnc18  immunosym  immunotherapy  Innate  ipilimumab  JITC  journalforimmunotherapyofcancer  LCSM  leukemia  lymphoma  lymphomas  Mechanisms  Medigene  melanoma  microbiome  microbiota  Myeloma  noveltargetspodcast  oncology  ovariancancer  PancreaticCancer  patients  PCFAcademy  pd1  PDL1  PMWC15  ProstateCancer  research  SGO2018  sgomtg  SITC15  smallcell  Stanford  StJude  Tales  Tcell  TCells  TCR  vaccine  Vaccines  VascularNormalization  WearWhite  WorldCancerDay 

Copy this bookmark:



description:


tags: